XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY AND NET LOSS PER SHARE - Antidilutive Securities (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 121,000,000 3,645,000,000 121,000,000 3,645,000,000
2021 Convertible Notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 0 2,958,000,000 0 2,958,000,000
Stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 12,000,000 12,000,000 12,000,000 12,000,000
Contingently redeemable convertible preferred stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 0 576,000,000 0 576,000,000
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 63,000,000 67,000,000 63,000,000 67,000,000
RSUs, ESPP, and other stock-based awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 46,000,000 32,000,000 46,000,000 32,000,000